Literature DB >> 2710166

Cloning of cDNAs encoding a 28 kilodalton antigen of Toxoplasma gondii.

J B Prince1, F G Araujo, J S Remington, J L Burg, J C Boothroyd, S D Sharma.   

Abstract

By screening cDNA libraries in lambda gt11 with antibodies raised against the previously described protective F3G3 antigen of Toxoplasma gondii, and subsequently screening with nucleic acid probes, we have isolated cDNA clones that encode a 28 kDa antigen of T. gondii that is likely one of the two antigenic components of the F3G3 antigen. The gene apparently exists as a single copy in the tachyzoite haploid genome of the three strains of T. gondii examined. Northern blot analyses revealed that the cDNAs hybridize with a major T. gondii RNA species of 1.1 kb. Together the cDNAs encompass 1051 bp of cDNA sequence containing an open reading frame with the capacity to encode a 28 kDa protein. Antibodies that were affinity purified using recombinant fusion proteins produced by two of the clones reacted on protein blots of whole T. gondii lysate with a single antigen having an apparent molecular mass of 28 kDa. Both recombinant fusion proteins reacted with IgG antibodies in sera of mice and humans infected with T. gondii and therefore might be useful for the development of diagnostic assays for T. gondii infection.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2710166     DOI: 10.1016/0166-6851(89)90014-5

Source DB:  PubMed          Journal:  Mol Biochem Parasitol        ISSN: 0166-6851            Impact factor:   1.759


  12 in total

1.  Generation of a restriction fragment length polymorphism linkage map for Toxoplasma gondii.

Authors:  L D Sibley; A J LeBlanc; E R Pfefferkorn; J C Boothroyd
Journal:  Genetics       Date:  1992-12       Impact factor: 4.562

2.  Comparison of dinucleotide frequency and codon usage in Toxoplasma and Plasmodium: evolutionary implications.

Authors:  A M Johnson
Journal:  J Mol Evol       Date:  1990-04       Impact factor: 2.395

3.  Expressed sequence tag analysis of the bradyzoite stage of Toxoplasma gondii: identification of developmentally regulated genes.

Authors:  I D Manger; A Hehl; S Parmley; L D Sibley; M Marra; L Hillier; R Waterston; J C Boothroyd
Journal:  Infect Immun       Date:  1998-04       Impact factor: 3.441

4.  New nucleotide sequence data on the EMBL File Server.

Authors: 
Journal:  Nucleic Acids Res       Date:  1989-11-25       Impact factor: 16.971

5.  Seroreactivity to and avidity for recombinant antigens in toxoplasmosis.

Authors:  Klaus-Ingmar Pfrepper; Gisela Enders; Marion Gohl; Doris Krczal; Harald Hlobil; Doris Wassenberg; Erwin Soutschek
Journal:  Clin Diagn Lab Immunol       Date:  2005-08

6.  The opportunistic pathogen Toxoplasma gondii deploys a diverse legion of invasion and survival proteins.

Authors:  Xing W Zhou; Björn F C Kafsack; Robert N Cole; Phil Beckett; Rong F Shen; Vern B Carruthers
Journal:  J Biol Chem       Date:  2005-07-07       Impact factor: 5.157

7.  Toxoplasma gondii: expression and characterization of a recombinant protein containing SAG1 and GRA2 in Pichia pastoris.

Authors:  Huaiyu Zhou; Qinmin Gu; Qunli Zhao; Jiaqin Zhang; Hua Cong; Ying Li; Shenyi He
Journal:  Parasitol Res       Date:  2006-10-21       Impact factor: 2.289

8.  Recombinant antigens to detect Toxoplasma gondii-specific immunoglobulin G and immunoglobulin M in human sera by enzyme immunoassay.

Authors:  D Aubert; G T Maine; I Villena; J C Hunt; L Howard; M Sheu; S Brojanac; L E Chovan; S F Nowlan; J M Pinon
Journal:  J Clin Microbiol       Date:  2000-03       Impact factor: 5.948

9.  Detection of human Toxoplasma-specific immunoglobulins A, M, and G with a recombinant Toxoplasma gondii rop2 protein.

Authors:  V Martin; M Arcavi; G Santillan; M R Amendoeira; E De Souza Neves; G Griemberg; E Guarnera; J C Garberi; S O Angel
Journal:  Clin Diagn Lab Immunol       Date:  1998-09

10.  Serodiagnosis of toxoplasmosis by using a recombinant form of the 54-kilodalton rhoptry antigen expressed in Escherichia coli.

Authors:  P van Gelder; F Bosman; F de Meuter; H van Heuverswyn; P Hérion
Journal:  J Clin Microbiol       Date:  1993-01       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.